Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy
2016 ◽
Vol 39
(2)
◽
pp. e45-e50
◽
2019 ◽
Vol 39
(2)
◽
pp. 211-216
◽